Literature DB >> 819602

Antibiotic synergism in enterococcal endocarditis.

J Carrizosa, D Kaye.   

Abstract

The recognition of enterococci highly resistant to streptomycin (S) raises questions concerning the choice of aminoglycoside in treatment of enterococcal endocarditis. Left-sided endocarditis was induced in rabbits with an S-sensitive enterococcus, strain 1 (inhibited by 125 mug per milliliter S), and an S-resistant enterococcus, strain 2 (resistant to 7,500 mug per milliliter S). Treatment was initiated 6 hours, 24 hours, or 3 days after infection with procaine penicillin (P) alone, P plus S, P plus gentamicin (G), or P plus sisomicin (Si). In rabbits infected with strain 1 for 6 hours before treatment, most vegetations were sterile after 3 days therapy with each combination but not with P alone which had mean log10 colony forming units per gram of vegetation (log CFU) of 2.5. With strain 2 the log CFU were lower (1.9 to 2.6) with each combination than with P (4.0). In rabbits infected with strain 1 for 24 hours and then given 9 days of therapy, the log CFU were decreased with each combination (2.0 to 2.3) as compared with P alone (4.9). With strain 2 the log CFU were lower with P plus G or Si (1.5 and 2.5) than with P alone or P plus S (4.5 AND 4.1). In rabbits infected with strain 1 for 3 days and then given 7 days of therapy, the log CFU were 4.1 to 5.5 with each combination and 6.7 with P. With strain 2 the log CFU was 4.0 with P plus G or Si as compared with 6.4 and 6.7 for P or P + S. These studies showed little difference between the 3 antibiotic combinations with the S-sensitive enterococcus or in early (6-hour) endocarditis caused by the S-resistant enterococcus. There was a large advantage of P plus G and P plus Si over P + S in more established (24 hour or 3 day) endocarditis caused by the S-resistant enterococcus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819602

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  32 in total

1.  Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.

Authors:  A S Bayer; J Tu
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci.

Authors:  A S Bayer; J Yih; L Hirano
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

3.  In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.

Authors:  L M Bush; J A Boscia; M Wendeler; P G Pitsakis; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 4.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.

Authors:  A S Bayer; P Lindsay; J Yih; L Hirano; D Lee; I K Blomquist
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

6.  Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.

Authors:  J Carrizosa; J Santoro; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

7.  Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.

Authors:  J Carrizosa; W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.

Authors:  M K Hayden; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.

Authors:  J A Boscia; W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.

Authors:  P A Guze; G M Kalmanson; L R Freedman; K Ishida; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.